140 related articles for article (PubMed ID: 21833453)
1. Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks.
Naldini A; Morena E; Belotti D; Carraro F; Allavena P; Giavazzi R
Thromb Haemost; 2011 Oct; 106(4):705-11. PubMed ID: 21833453
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of naïve monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only.
Nieuwenhuizen L; Falkenburg WJ; Schutgens RE; Roosendaal G; van Veghel K; Biesma DH; Lafeber FP
Scand J Immunol; 2013 May; 77(5):339-49. PubMed ID: 23421536
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes.
Naldini A; Bernini C; Pucci A; Carraro F
J Leukoc Biol; 2005 Sep; 78(3):736-44. PubMed ID: 15961578
[TBL] [Abstract][Full Text] [Related]
4. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS
J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318
[TBL] [Abstract][Full Text] [Related]
5. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells.
Fan Y; Zhang W; Mulholland M
J Surg Res; 2005 Dec; 129(2):196-201. PubMed ID: 16143343
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses.
Naldini A; Aarden L; Pucci A; Bernini C; Carraro F
Br J Pharmacol; 2003 Nov; 140(5):980-6. PubMed ID: 14517182
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
8. [-Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma-].
Radke J; Schmidt D; Böhme M; Schmidt U; Weise W; Morenz J
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):83-7. PubMed ID: 8647364
[TBL] [Abstract][Full Text] [Related]
9. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
10. Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells.
Zhang T; Ma Z; Wang R; Wang Y; Wang S; Cheng Z; Xu H; Jin X; Li W; Wang X
Cancer Immunol Immunother; 2010 Jul; 59(7):1097-108. PubMed ID: 20352429
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation.
Johnson K; Choi Y; DeGroot E; Samuels I; Creasey A; Aarden L
J Immunol; 1998 May; 160(10):5130-5. PubMed ID: 9590265
[TBL] [Abstract][Full Text] [Related]
13. Production of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cells.
Nowak M; Klink M; Glowacka E; Sulowska Z; Kulig A; Szpakowski M; Szyllo K; Tchorzewski H
Scand J Immunol; 2010 Feb; 71(2):91-8. PubMed ID: 20384860
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
Allavena P; Peccatori F; Maggioni D; Erroi A; Sironi M; Colombo N; Lissoni A; Galazka A; Meiers W; Mangioni C
Cancer Res; 1990 Nov; 50(22):7318-23. PubMed ID: 2121337
[TBL] [Abstract][Full Text] [Related]
18. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
19. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells.
Liu J; Schuff-Werner P; Steiner M
Biochem Biophys Res Commun; 2006 Apr; 343(1):183-9. PubMed ID: 16530725
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
